BNTC

Benitec Biopharma INC

-$81.5M

Net Activity

Institutions Holding

88

Popularity Rank

#4726

Avg Weight

0.13%

Total Value

$345.0M

Ownership Trend

88 institutions currently hold BNTC, with 56 net buyers and 22 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

22

Net Buying Institutions

56

Key Holders

View all 88 holding institutions

Quarterly Activity

Recent Activity

+$109.3M

Total Buy Value

$76.0M

Total Sell Value

New buy21
Trim14
Add35
Sold out8

56

Net Buyers

22

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BENITEC BIOPHARMA INC (BNTC)?
Major stakeholders currently include Suvretta Capital Management, LLC ($123.0M), Janus Henderson Group PLC ($30.7M), Franklin Resources INC ($25.3M). Based on the latest 13F filings, there are a total of 88 tracked investment funds and institutions maintaining positions in BNTC.
What is the overall institutional sentiment toward BNTC recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $81.5M, driven by 56 managers accumulating shares while 22 reduced their exposure.
Which institutions have been selling or reducing their BNTC positions?
In the latest period, 14 funds trimmed their holdings, and 8 managers completely exited their positions. The aggregate reported sell value was $76.0M.
Are there any notable investors adding BNTC to their portfolios?
Yes, buying activity remains notable. 21 institutions opened new positions in {ticker}, and 35 existing holders added to their shares. The total reported buy value for the quarter amounted to $109.3M.

Related Stocks